Log in

Relevant bibliographies by topics / Premenstrual syndrome - Homeopathic treatment / Journal articles

To see the other types of publications on this topic, follow the link: Premenstrual syndrome - Homeopathic treatment.

Journal articles on the topic 'Premenstrual syndrome - Homeopathic treatment'

Author: Grafiati

Published: 4 June 2021

Last updated: 17 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Premenstrual syndrome - Homeopathic treatment.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Colas, Aurélie, Laurence Terzan, Marie-France Bordet, and Karine Danno. "Homeopathic treatment of premenstrual syndrome: a case series." Homeopathy 102, no. 01 (January 2013): 59–65. http://dx.doi.org/10.1016/j.homp.2012.10.004.

Full text

Abstract:

Objective: Observational, prospective study to describe the homeopathic management of premenstrual syndrome (PMS) by a group of French physicians.Method: Women with PMS for >3 months were prescribed individualized homeopathic treatment. The intensity of 10 clinical symptoms of PMS was scored individually at inclusion and at a 3–6 month follow-up visit: absent = 0, mild = 1, moderate = 2, severe = 3. Total symptom score (range: 0–30) was calculated and compared for each patient at inclusion and at follow-up. PMS impact on daily activities (quality of life, QoL) was compared at inclusion and follow-up as: none, mild, moderate, severe, very severe.Results: Twenty-three women were prescribed homeopathic treatment only (mean age: 39.7 years). Folliculinum (87%) was the most frequently prescribed homeopathic medicine followed by Lachesis mutus (52.2%). The most common PMS symptoms (moderate or severe) at inclusion were: irritability, aggression and tension (87%), mastodynia (78.2%) and weight gain and abdominal bloating (73.9%); and the most common symptoms at follow-up were: irritability, aggression and tension (39.1%), weight gain and abdominal bloating (26.1%) and mastodynia (17.4%). Mean global score for symptom intensity was 13.7 at inclusion and 6.3 at follow-up. The mean decrease in score (7.4) was statistically significant (p < 0.0001). Twenty-one women reported that their QoL also improved significantly (91.3%; p < 0.0001).Conclusions: Homeopathic treatment was well tolerated and seemed to have a positive impact on PMS symptoms. Folliculinum was the most frequent homeopathic medicine prescribed. There appears to be scope for a properly designed, randomized, placebo-controlled trial to investigate the efficacy of individual homeopathic medicines in PMS.

APA, Harvard, Vancouver, ISO, and other styles

2

Yakir, M., S. Kreitler, A. Brzezinski, G. Vithoulkas, M. Oberbaum, and Z. Bentwich. "Effects of homeopathic treatment in women with premenstrual syndrome: a pilot study." British Homeopathic Journal 90, no. 03 (July 2001): 148–53. http://dx.doi.org/10.1054/homp.1999.0491.

Full text

Abstract:

AbstractAlternative therapies in general, and homeopathy in particular, lack clear scientific evaluation of efficacy. Controlled clinical trials are urgently needed, especially for conditions that are not helped by conventional methods. The objective of this work was to assess the efficacy of homeopathic treatment in relieving symptoms associated with premenstrual syndrome (PMS). It was a randomised controlled double-blind clinical trial. Two months baseline assessment with post-intervention follow-up for 3 months was conducted at Hadassah Hospital outpatient gynaecology clinic in Jerusalem in Israel 1992–1994. The subjects were 20 women, aged 20–48, suffering from PMS. Homeopathic intervention was chosen individually for each patient, according to a model of symptom clusters. Recruited volunteers with PMS were treated randomly with one oral dose of a homeopathic medication or placebo. The main outcome measure was scores of a daily menstrual distress questionnaire (MDQ) before and after treatment. Psychological tests for suggestibility were used to examine the possible effects of suggestion. Mean MDQ scores fell from 0.44 to 0.13 (P<0.05) with active treatment, and from 0.38 to 0.34 with placebo (NS). (Between group P=0.057). Improvement >30% was observed in 90% of patients receiving active treatment and 37.5% receiving placebo (P=0.048). Homeopathic treatment was found to be effective in alleviating the symptoms of PMS in comparison to placebo. The use of symptom clusters in this trial may offer a novel approach that will facilitate clinical trials in homeopathy. Further research is in progress.

APA, Harvard, Vancouver, ISO, and other styles

3

Klein-Laansma, Christien T., Alexander L. B. Rutten, Jean Pierre C. H. Jansen, Herman van Wietmarschen, and Miek C. Jong. "Evaluation of a Prognostic Homeopathic Questionnaire for Women with Premenstrual Disorders." Complementary Medicine Research 25, no. 3 (2018): 173–82. http://dx.doi.org/10.1159/000487318.

Full text

Abstract:

Background/Aims: Validation of treatments with individually prescribed homeopathic medicines is a challenging task. A prognostic homeopathic patient questionnaire containing 140 keynote symptoms (highly characteristic of a specific homeopathic medicine) and an electronic algorithm to process the answers were used in 2 clinical studies. The algorithm outcome, based on total symptom scores, indicated 1 of 11 pre-selected homeopathic medicines for women with premenstrual syndrome and premenstrual dysphoric disorder (PMS/PMDD). Aims were (1) to estimate the prognostic values of keynote symptoms and (2) to evaluate the reliability of the homeopathic medicine ranking in the algorithm outcome. Methods: The prevalence of specific keynote symptoms was calculated in 145 women diagnosed with PMS/PMDD and in 40 included women with favorable outcomes using 1 of the 11 homeopathic medicines. Likelihood ratios (LRs) of the keynote symptoms were calculated. Pearson's correlations were calculated between 2 sets of total algorithm scores for 11 homeopathic medicines, obtained at 2 time points. Results: (1) A positive prognostic value (LR ≥ 1.5) was found in 34 keynote symptoms with a prevalence of 10-40%, with 10 symptoms already being connected to the corresponding homeopathic medicine in the algorithm. For example, the symptom ‘common cold of the nose before menstruation' indicated Magnesium carbonicum with LR = 7.47 (confidence interval (CI) 3.90-14.28). (2) Pearson's correlations for the reliability evaluation varied from 0.69 to 0.84. Conclusions: Recommendations can be made to improve the PMS algorithm with more accurate keynote symptoms. The prognostic questionnaire proved a reliable tool to rank 11 homeopathic medicines by total scores, based on keynote symptoms. This PMS algorithm can be used for the treatment of PMS/PMDD in clinical practice.

APA, Harvard, Vancouver, ISO, and other styles

4

Yakir, Michal, Christien T. Klein-Laansma, Shulamith Kreitler, Amnon Brzezinski, Menachem Oberbaum, George Vithoulkas, and Zvi Bentwich. "A Placebo-Controlled Double-Blind Randomized Trial with Individualized Homeopathic Treatment Using a Symptom Cluster Approach in Women with Premenstrual Syndrome." Homeopathy 108, no. 04 (August 21, 2019): 256–69. http://dx.doi.org/10.1055/s-0039-1691834.

Full text

Abstract:

Background In a double-blind placebo-controlled randomized trial with parallel groups, the efficacy of individually prescribed homeopathic medicines was evaluated in women with premenstrual syndrome (PMS). Methods In an outpatient department of a university clinic in Jerusalem, Israel (1996–1999), women with PMS, aged 18 to 50 years, entered a 2-month screening phase with prospective daily recording of premenstrual symptoms by the Menstrual Distress Questionnaire (MDQ). They were included after being diagnosed with PMS. A reproducible treatment protocol was used: women received a homeopathic prescription based on symptom clusters identified in a questionnaire. The symptoms were verified during a complementary, structured, interview. Only women whose symptoms matched the symptom profile of one of 14 pre-selected homeopathic medicines were included. Each participant was administered active medicine or placebo via random allocation. Primary outcome measures were differences in changes in mean daily premenstrual symptom (PM) scores by the MDQ. Analysis was by intention-to-treat. Results A total of 105 women were included: 49 were randomized to active medicine and 56 to placebo. Forty-three women in the active medicine group and 53 in the placebo group received the allocated intervention with at least one follow-up measurement and their data were analyzed. Significantly greater improvement of mean PM scores was measured in the active medicine group (0.443 [standard deviation, SD, 0.32] to 0.287 [SD, 0.20]) compared to placebo (0.426 [SD, 0.34] to 0.340 [SD, 0.39]); p = 0.043. Conclusions Individually prescribed homeopathic medicines were associated with significantly greater improvement of PM scores in women with PMS, compared to placebo. Replication, with larger sample size and other refinements, is recommended to confirm the efficacy of this treatment in other settings.

APA, Harvard, Vancouver, ISO, and other styles

5

Klein-Laansma, C. T., J. C. H. Jansen, A. J. W. van Tilborgh, D. A. W. M. Van der Windt, R. T. Mathie, and A. L. B. Rutten. "Semi-standardised homeopathic treatment of premenstrual syndrome with a limited number of medicines: Feasibility study." Homeopathy 99, no. 3 (July 2010): 192–204. http://dx.doi.org/10.1016/j.homp.2010.05.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Wandile, Pranali. "Fibromyalgia Management with Homeopathy." Homœopathic Links 30, no. 04 (December 2017): 245–49. http://dx.doi.org/10.1055/s-0037-1608614.

Full text

Abstract:

AbstractFibromyalgia is one of the most common genetically inherited chronic affective spectrum disorders (ASD). Other ASD disorders are psychiatric and medical conditions such as irritable bowel syndrome (IBS), migraine, cataplexy—attention-deficit/hyperactivity disorder, bulimia nervosa, dysthymic disorder, generalised anxiety disorder, major depressive disorder (MDD), obsessive-compulsive disorder, panic disorder, posttraumatic stress disorder, premenstrual dysphoric disorder, rheumatoid arthritis, and social phobia. Apart from genetic factors, neuroendocrine, autonomic nervous system abnormalities, psychosocial variables and environmental stressors contribute in the pathophysiology of fibromyalgia and other associated disorders. In this article, we reviewed etiology, pathophysiology, maintaining and triggering factors, and various treatment options for fibromyalgia. Apart from the pain management, this condition can be managed by ancillary method of treatment. However, due to the genetic cause of the disease, there is very little to offer for its complete cure. Homeopathic miasmatic treatment focuses on the genetic cause of the disease for its complete annihilation while also providing various acute remedies for the temporary pain management. We reviewed homeopathy treatment management and various remedies, which have much to offer for this chronic condition while considering its genetic, triggering and maintaining factors.

APA, Harvard, Vancouver, ISO, and other styles

7

Jones, Angela. "Homeopathic treatment for premenstrual symptoms." Journal of Family Planning and Reproductive Health Care 29, no. 1 (January 1, 2003): 25–28. http://dx.doi.org/10.1783/147118903101196855.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Cox, Michael. "Size does matter and Homeopathic treatment of premenstrual symptoms." Journal of Family Planning and Reproductive Health Care 29, no. 3 (July 1, 2003): 172. http://dx.doi.org/10.1783/147118903101197719.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Dennerstein, Lorraine, Carol Morse, Gordon Gotts, James Brown, Margery Smith, Jeremy Oats, and Graham Burrows. "Treatment of premenstrual syndrome." Journal of Affective Disorders 11, no. 3 (November 1986): 199–205. http://dx.doi.org/10.1016/0165-0327(86)90070-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Tucker, Joan S., and Richard E. Whalen. "Premenstrual Syndrome." International Journal of Psychiatry in Medicine 21, no. 4 (December 1991): 311–41. http://dx.doi.org/10.2190/1cet-d610-uheb-yng6.

Full text

Abstract:

The Premenstrual Syndrome (PMS) was described as a unique entity meriting therapeutic attention in 1931. Although researchers in the area have failed to develop a widely accepted definition of PMS, substantial progress has been made in describing the variety of psychobiological profiles encompassed by this syndrome, particularly with respect to its typical symptoms, cyclical nature, symptoms recurrence and severity. Therapies ranging from diet and exercise to vitamin, hormone and drug treatment have been proposed. While none is more efficacious than placebo, several have been popularized. Our failure to develop adequate treatment may reflect our lack of understanding of either the psychosocial or biological factors involved in PMS. This, in turn, may reflect inadequate theoretical development in this research area. We provide a critical assessment of research on PMS, suggest a framework for theoretical development and advocate research strategies that might provide insights into the etiology of the premenstrual syndrome.

APA, Harvard, Vancouver, ISO, and other styles

11

Sampson, Gwyneth A., Patricia R. M. Heathcote, Jennifer Wordsworth, Philip Prescott, and Alan Hodgson. "Premenstrual Syndrome." British Journal of Psychiatry 153, no. 2 (August 1988): 232–35. http://dx.doi.org/10.1192/bjp.153.2.232.

Full text

Abstract:

A double-blind, cross-over, placebo-controlled study of dydrogesterone (10 mg b.d.) in the treatment of premenstrual syndrome is described. Two groups of women were studied: secondarily referred hospital clinic patients, and self-referred patients. Only one-third of patients screened completed the study. All patients showed significant improvements in symptom scores during the course of the study, the only significant difference between placebo- and dydrogesterone-treated patients being an increase in frequency of breast tenderness and a decrease in pain with menstrual bleeding in the latter.

APA, Harvard, Vancouver, ISO, and other styles

12

Pearlstein, Teri. "Nonpharmacologic Treatment of Premenstrual Syndrome." Psychiatric Annals 26, no. 9 (September 1, 1996): 590–94. http://dx.doi.org/10.3928/0048-5713-19960901-13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Kim, Tak. "Medical Treatment of Premenstrual Syndrome." Journal of the Korean Medical Association 48, no. 7 (2005): 672. http://dx.doi.org/10.5124/jkma.2005.48.7.672.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Deicken, Raymond F. "Verapamil treatment of premenstrual syndrome." Biological Psychiatry 24, no. 6 (October 1988): 689–92. http://dx.doi.org/10.1016/0006-3223(88)90142-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Yakir, M., S. Kreitler, M. Oberbaum, A. Bzizinsky, G. Vithoulkas, and Z. Bentwich. "Homoeopathic treatment of premenstrual syndrome." British Homeopathic Journal 84, no. 03 (July 1995): 182–83. http://dx.doi.org/10.1016/s0007-0785(05)80090-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Alberts, Phillip S., and Michael S. Alberts. "Unvalidated Treatment of Premenstrual Syndrome." International Journal of Mental Health 19, no. 3 (September 1990): 69–80. http://dx.doi.org/10.1080/00207411.1990.11449174.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Di Carlo, C., G. Bifulco, M. Pellicano, V. Napolitano, and C. Nappi. "Hormonal treatment of premenstrual syndrome." Cephalalgia 17, no. 20_suppl (December 1997): 17–19. http://dx.doi.org/10.1177/0333102497017s2006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Guo, Zheng-Rong, and Liang-Xiao Ma. "Acupuncture Treatment for Premenstrual Syndrome." Medical Acupuncture 25, no. 3 (June 2013): 200–204. http://dx.doi.org/10.1089/acu.2012.0913.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Keye, William R. "Medical Treatment of Premenstrual Syndrome." Canadian Journal of Psychiatry 30, no. 7 (November 1985): 483–88. http://dx.doi.org/10.1177/070674378503000705.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Ward, Michael W., and Teresa D. Holimon. "Calcium Treatment for Premenstrual Syndrome." Annals of Pharmacotherapy 33, no. 12 (December 1999): 1356–58. http://dx.doi.org/10.1345/aph.19023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Татарчук, Т. Ф., Н. Ф. Захаренко, and I. П. Маноляк. "Premenstrual syndrome. Pathogenetic aspects of treatment." Reproductive Endocrinology, no. 43 (December 3, 2018): 50–54. http://dx.doi.org/10.18370/2309-4117.2018.43.50-54.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Pakharenko, L. V. "Premenstrual syndrome: pathogenesis, prevention and treatment." HEALTH OF WOMAN, no. 4(110) (May 30, 2016): 52–55. http://dx.doi.org/10.15574/hw.2016.110.52.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

McDonough, Paul G., Guy E. Abraham, and Joel T. Hargrove. "Diagnosis and Treatment of Premenstrual Syndrome." Fertility and Sterility 54, no. 1 (July 1990): 178–79. http://dx.doi.org/10.1016/s0015-0282(16)53661-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pariser, Stephen F., Stephen L. Stern, Myron L. Shank, James M. Falko, Richard W. O'Shaughnessy, and Chad I. Friedman. "Premenstrual syndrome: Concerns, controversies, and treatment." American Journal of Obstetrics and Gynecology 153, no. 6 (November 1985): 599–604. http://dx.doi.org/10.1016/s0002-9378(85)80241-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Fankhauser, Martha P. "Treatment of Dysmenorrhea and Premenstrual Syndrome." Journal of the American Pharmaceutical Association (1996) 36, no. 8 (August 1996): 503–13. http://dx.doi.org/10.1016/s1086-5802(16)30106-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Milewicz, Andrzej, and Diana Jedrzejuk. "Premenstrual syndrome: From etiology to treatment." Maturitas 55 (November 2006): S47—S54. http://dx.doi.org/10.1016/j.maturitas.2006.06.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

MENKES, DAVID B., EBRAHIM TAGHAVI, PATSY A. MASON, GEORGE F. S. SPEARS, and RICHARD C. HOWARD. "Fluoxetine Treatment of Severe Premenstrual Syndrome." Obstetrical & Gynecological Survey 48, no. 2 (February 1993): 131. http://dx.doi.org/10.1097/00006254-199302000-00022.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

KRAEMER, GINGER R., and ROBERT R. KRAEMER. "Premenstrual Syndrome: Diagnosis and Treatment Experiences." Journal of Women's Health 7, no. 7 (September 1998): 893–907. http://dx.doi.org/10.1089/jwh.1998.7.893.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Mortola, Joseph F. "Pathophysiology and treatment of premenstrual syndrome." Current Opinion in Endocrinology and Diabetes 2, no. 6 (December 1995): 483–92. http://dx.doi.org/10.1097/00060793-199512000-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Montazeri, Shabnam. "Non-pharmacological treatment of premenstrual syndrome." African Journal of Midwifery and Women's Health 5, no. 3 (July 2011): 148–52. http://dx.doi.org/10.12968/ajmw.2011.5.3.148.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Rickels, Karl, Ellen Freeman, and Steven Sondheimer. "BUSPIRONE IN TREATMENT OF PREMENSTRUAL SYNDROME." Lancet 333, no. 8641 (April 1989): 777. http://dx.doi.org/10.1016/s0140-6736(89)92591-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Lauersen, Niels H. "Recognition and Treatment of Premenstrual Syndrome." Nurse Practitioner 10, no. 3 (March 1985): 11–22. http://dx.doi.org/10.1097/00006205-198503000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Lauersen, Niels H. "Recognition and Treatment of Premenstrual Syndrome." Nurse Practitioner 10, no. 3 (March 1985): 11–22. http://dx.doi.org/10.1097/00006205-198510030-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Brandenburg, S., H. Tuynman-Qua, R. Verheij, and L. Pepplinkhuizen. "Treatment of premenstrual syndrome with fluoxetine." International Clinical Psychopharmacology 8, no. 4 (1993): 315–18. http://dx.doi.org/10.1097/00004850-199300840-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Menkes, D. B., E. Taghavi, P. A. Mason, G. F. Spears, and R. C. Howard. "Fluoxetine treatment of severe premenstrual syndrome." BMJ 305, no. 6849 (August 8, 1992): 346–47. http://dx.doi.org/10.1136/bmj.305.6849.346.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Dhar, Veena, and Beverley E. Pearson Murphy. "The premenstrual syndrome and its treatment." Journal of Steroid Biochemistry and Molecular Biology 39, no. 2 (August 1991): 275–81. http://dx.doi.org/10.1016/0960-0760(91)90073-e.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Rapkin, Andrea. "A review of treatment of premenstrual syndrome & premenstrual dysphoric disorder." Psychoneuroendocrinology 28 (August 2003): 39–53. http://dx.doi.org/10.1016/s0306-4530(03)00096-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Tamashiro, Leiliane Aparecida Diniz, Bianca Cristina Tunes Nakad, Joel Rennó, Antônio Geraldo da Silva, Renan Rocha, Amaury Cantilino, Gislene Valadares, and Hewdy Lobo Ribeiro. "Premenstrual syndrome and premenstrual dysphoric disorder: cognitive behavioral therapy as treatment." Revista Debates em Psiquiatria Ano 7 (December 1, 2017): 15–23. http://dx.doi.org/10.25118/2236-918x-7-6-2.

Full text

Abstract:

Objetivo: Elucidar as principais hipóteses atuais sobre o transtorno disfórico pré-menstrual (TDPM), a síndrome pré-menstrual (SPM) e a terapia cognitiva comportamental (TCC) como tratamento. Método: Foi realizada uma pesquisa nos bancos de dados PubMed, Cochrane e BIREME (LILACS/BVS), nos idiomas português, espanhol e inglês, no período de 2000 a 2017, utilizando os seguintes descritores: transtorno disfórico pré-menstrual, síndrome prémenstrual e terapia cognitiva comportamental. Resultados: Um total de 107 estudos enquadrou-se nos critérios de inclusão – artigos de revisão da literatura, estudos do tipo corte transversal, estudos do tipo coorte prospectivo e estudo do tipo coorte retrospectivo. Cento e cinco estudos identificaram fatores fundamentais para o desenvolvimento da TDPM – as hipóteses da função ovariana, função hormonal, neurotransmissores, genética e fatores ambientais e vulnerabilidade. Desde 2009, temos estudos sobre a TCC como tratamento de primeira linha. Conclusão: Os fundamentos do TDPM podem ser vistos como uma complexa multiplicidade de fatores. Ainda não há nada conclusivo; futuras pesquisas são necessárias para definir os processos etiopatogênicos do TDPM. A TCC demonstrou sua eficácia como tratamento de primeira linha para SPM e TDPM.

APA, Harvard, Vancouver, ISO, and other styles

39

Kuznetsova, I. V. "Modern views on treatment of premenstrual syndrome." Medical alphabet 3, no. 25 (November 19, 2019): 18–23. http://dx.doi.org/10.33667/2078-5631-2019-3-25(400)-18-23.

Full text

Abstract:

Premenstrual syndrome (PMS) is a common disease associated with a serious decrease in the quality of life of a woman, a violation of habitual life and working capacity. The etiology of PMS and premenstrual dysphoric disorder (PMDD) has not yet been established, but it is clear that their development is associated with fluctuations in hormone levels within the ovulatory menstrual cycle and impaired balance of neurohormones in the central nervous system (CNS). In connection with these ideas, in the treatment of PMS, two main directions are used: the suppression of hormonal fluctuations and the effect on the central nervous system. Among the large number of drugs claimed for the treatment of PMS and PMDD, the so-called alternative therapy deserves special attention, in which several methods have a worthy evidence base for positive effects.

APA, Harvard, Vancouver, ISO, and other styles

40

Özeren, Semih, Aydın Çorakçi, Yücesoy İzzet, Ramazan Mercan, and Gülseren Erhan. "Fluoxetine in the treatment of premenstrual syndrome." European Journal of Obstetrics & Gynecology and Reproductive Biology 73, no. 2 (June 1997): 167–70. http://dx.doi.org/10.1016/s0301-2115(97)02741-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

FREEMAN, ELLEN W., KARL RICKELS, STEVEN J. SONDHEIMER, ANDRE DENIS, SAMANTHA PFEIFER, and STACIE WEIL. "Nefazodone in the Treatment of Premenstrual Syndrome." Journal of Clinical Psychopharmacology 14, no. 3 (June 1994): 180???186. http://dx.doi.org/10.1097/00004714-199406000-00005.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Robinson, Gail Erlick, and Paul E. Garfinkel. "Problems in the Treatment of Premenstrual Syndrome." Canadian Journal of Psychiatry 35, no. 3 (April 1990): 199–206. http://dx.doi.org/10.1177/070674379003500301.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Schmidt, Peter J. "Alprazolam in the Treatment of Premenstrual Syndrome." Archives of General Psychiatry 50, no. 6 (June 1, 1993): 467. http://dx.doi.org/10.1001/archpsyc.1993.01820180069007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Indusekhar, Radha, and Shaughn O'Brien. "Premenstrual syndrome: current approaches to drug treatment." Prescriber 17, no. 9 (May 5, 2006): 23–29. http://dx.doi.org/10.1002/psb.372.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

NIKOLAI, THOMAS F., GERALD M. MULLIGAN, ROBERT K. GRIBBLE, PAUL G. HARKINS, PAUL R. MEIER, and RONALD C. ROBERTS. "Thyroid Function and Treatment in Premenstrual Syndrome." Journal of Clinical Endocrinology & Metabolism 70, no. 4 (April 1990): 1108–13. http://dx.doi.org/10.1210/jcem-70-4-1108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ghazanfarpour, Masumeh, Masumeh Kaviani, Nasrin Asadi, Fariborz Ghaffarpasand, Samaneh Ziyadlou, Hamid R. Tabatabaee, and Maryam Dehghankhalili. "Hypericum perforatumfor the treatment of premenstrual syndrome." International Journal of Gynecology & Obstetrics 113, no. 1 (March 21, 2011): 84–85. http://dx.doi.org/10.1016/j.ijgo.2010.11.007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Eriksson, E., J. Endicott, B. Andersch, J. Angst, K. Demyttenaere, F. Facchinetti, M. Lanczik, et al. "New perspectives on the treatment of premenstrual syndrome and premenstrual dysphoric disorder." Archives of Women's Mental Health 4, no. 4 (May 1, 2002): 111–19. http://dx.doi.org/10.1007/s007370200009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Martinez, Bruno. "Folliculinum: Efficacy in premenstrual syndrome." British Homeopathic Journal 79, no. 02 (April 1990): 104–5. http://dx.doi.org/10.1016/s0007-0785(05)80156-5.

Full text

Abstract:

SummaryThe severity of Premenstrual Syndrome (PMS) and the effect of Folliculinum 9 cH in 32 patients was analyzed using a questionnaire. Symptoms of PMS were troublesome in 84% of patients prescribed Folliculinum, 88% of patients showed a satisfactory response to treatment.

APA, Harvard, Vancouver, ISO, and other styles

49

MAHARAJ, SHALINI, and KENNETH TREVINO. "A Comprehensive Review of Treatment Options for Premenstrual Syndrome and Premenstrual Dysphoric Disorder." Journal of Psychiatric Practice 21, no. 5 (September 2015): 334–50. http://dx.doi.org/10.1097/pra.0000000000000099.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Khoo, Soo Keat, Claud Munro, and Diana Battistutta. "Evening primrose oil and treatment of premenstrual syndrome." Medical Journal of Australia 153, no. 4 (August 1990): 189–92. http://dx.doi.org/10.5694/j.1326-5377.1990.tb136857.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!